ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

NRXS Neuraxis Inc

2,70
-0,10 (-3,57%)
20 Jun 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Neuraxis Inc NRXS AMEX Common Stock
  Änderung Änderung % Aktuell Zeit
-0,10 -3,57% 2,70 22:00:10
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,85 2,50 2,90 2,70 2,80
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
07.6.202415:00GLOBENeurAxis Announces New Submission to the FDA for the..
22.5.202414:00GLOBENeurAxis Reports First Quarter 2024 Financial Results
21.5.202415:00GLOBENeurAxis to Participate in the Lytham Partners Spring 2024..
20.5.202422:18EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
16.5.202415:00GLOBENeurAxis Announces New Medical Policy Coverage For Nearly..
15.5.202422:30GLOBENeurAxis to Host First Quarter 2024 Results and Business..
15.5.202422:15EDGAR2Form NT 10-Q - Notification of inability to timely file Form..
23.4.202415:00GLOBENeurAxis Announces New Medical Policy Coverage in North..
09.4.202422:05GLOBENeurAxis Reports Fourth Quarter and Fiscal Year 2023..
01.4.202422:15GLOBENeurAxis to Host Fourth Quarter and Full Year 2023 Results..
27.3.202414:00GLOBENeurAxis Announces IB-Stim Results from a Large, Pediatric,..
11.3.202414:00GLOBENeurAxis Announces Highmark BCBS Policy Coverage
11.3.202413:50EDGAR2Form 8-K - Current report
04.3.202415:00GLOBENeurAxis Announces Blue Cross and Blue Shield of Kansas City..
27.2.202417:00GLOBENeurAxis to Present at Oppenheimer 34th Annual Healthcare..
15.2.202423:00EDGAR2Form 8-K - Current report
31.1.202415:15EDGAR2Form 8-K - Current report
20.12.202315:00GLOBENeurAxis, Inc. Issues Letter to Shareholders from Brian..
19.12.202323:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19.12.202323:00EDGAR2Form 8-K - Current report
20.11.202323:30GLOBENeurAxis Reports Third Quarter 2023 Financial Results
20.11.202323:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15.11.202315:00GLOBENeurAxis Announces CareFirst BCBS Policy Coverage
14.11.202315:00GLOBENeurAxis Secures $3 Million Financing
08.11.202315:00GLOBENeurAxis Signs Exclusive Option Agreement with University of..
26.9.202315:00GLOBENeurAxis Announces Results of Comparative Study of IB-Stim™..
22.9.202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
21.9.202314:30EDGAR2Form 8-K - Current report
21.9.202314:00GLOBENeurAxis Reports Second Quarter 2023 Financial Results
13.9.202322:15EDGAR2Form 3 - Initial statement of beneficial ownership of..
13.9.202315:00GLOBENeurAxis to Present at the Gilmartin Group Emerging Growth..
12.9.202315:00GLOBENeurAxis Announces Publication of Prospective Study Showing..
29.8.202317:49APSNews Brief: NeurAxis Inc.
29.8.202315:00GLOBENeurAxis Highlights Pediatric Post-Concussion Clinical Study
24.8.202315:00GLOBENeurAxis Highlights Strength of its Board of Directors
22.8.202315:00GLOBENeurAxis Highlights Two Independent Studies Showing Benefits..
17.8.202315:02GLOBENeurAxis Announces Over $8 Million in IB-Stim™ Revenue
10.8.202315:00GLOBEExchange Listing Client, Neuraxis, Inc., Successfully..